Journey Medical Corp (DERM)vsViatris Inc (VTRS)
DERM
Journey Medical Corp
$5.12
+3.23%
HEALTHCARE · Cap: $147.33M
VTRS
Viatris Inc
$19.20
+2.29%
HEALTHCARE · Cap: $21.56B
Smart Verdict
WallStSmart Research — data-driven comparison
Viatris Inc generates 21515% more annual revenue ($14.74B vs $68.18M). VTRS leads profitability with a -2.8% profit margin vs -8.9%. VTRS earns a higher WallStSmart Score of 42/100 (D).
DERM
Avoid28
out of 100
Grade: F
VTRS
Hold42
out of 100
Grade: D
Intrinsic Value Comparison
Multi-model valuation · Graham Formula
Margin of Safety
-60.8%
Fair Value
$4.97
Current Price
$5.12
$0.15 premium
Margin of Safety
-82.5%
Fair Value
$8.84
Current Price
$19.20
$10.36 premium
Key Strengths & Concerns
Side-by-side fundamental analysis
Key Strengths
Revenue surging 23.3% year-over-year
Reasonable price relative to book value
Areas to Watch
0.0% earnings growth
Smaller company, higher risk/reward
Operating margin of 2.5%
Weak financial health signals
4.9% revenue growth
Expensive relative to growth rate
ROE of -2.9% — below average capital efficiency
Earnings declined 70.6%
Comparative Analysis Report
WallStSmart ResearchBull Case : DERM
The strongest argument for DERM centers on Revenue Growth. Revenue growth of 23.3% demonstrates continued momentum.
Bull Case : VTRS
The strongest argument for VTRS centers on Price/Book.
Bear Case : DERM
The primary concerns for DERM are EPS Growth, Market Cap, Operating Margin.
Bear Case : VTRS
The primary concerns for VTRS are Revenue Growth, PEG Ratio, Return on Equity.
Key Dynamics to Monitor
DERM profiles as a growth stock while VTRS is a turnaround play — different risk/reward profiles.
DERM carries more volatility with a beta of 1.11 — expect wider price swings.
DERM is growing revenue faster at 23.3% — sustainability is the question.
VTRS generates stronger free cash flow (329M), providing more financial flexibility.
Bottom Line
VTRS scores higher overall (42/100 vs 28/100). Both earn "Hold" and "Avoid" ratings respectively — the choice depends on your investment horizon and risk tolerance.
This analysis is generated from publicly available financial data. Not financial advice.
Journey Medical Corp
HEALTHCARE · DRUG MANUFACTURERS - SPECIALTY & GENERIC · USA
Dermira, Inc., a biopharmaceutical company, develops and markets therapies for patients with dermatological diseases in the United States.
Viatris Inc
HEALTHCARE · DRUG MANUFACTURERS - SPECIALTY & GENERIC · USA
Viatris Inc. is an American global healthcare company headquartered in Canonsburg, Pennsylvania.
Visit Website →Compare with Other DRUG MANUFACTURERS - SPECIALTY & GENERIC Stocks
Want to dig deeper into these stocks?